Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Escalation Study to Assess the Safety and Efficacy of SL-1002 Injectable for Treatment of Knee Pain Associated With Osteoarthritis

NCT05470608 is registered in ClinicalTrials.gov with Saol Therapeutics Inc as lead sponsor.

NCT NCT05470608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05470608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Escalation Study to Assess the Safety and Efficacy of SL-1002 Injectable for Treatment of Knee Pain Associated With Osteoarthritis
Lead sponsor
Saol Therapeutics Inc
Phase
Phase 2
Overall status
Unknown status
Start date
June 13, 2022
Completion date
January 31, 2024
Enrollment
132 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee pain